Lv31
350 积分 2023-09-07 加入
Recombinant RAGE antagonist peptide promotes alveolar epithelial cell regeneration via the RAGE/MAPKs/MMP2 pathway in emphysema
2小时前
已关闭
Targeting YAP-mediated Hepatic Stellate Cell Death Susceptibility and Senescence for Treatment of Liver Fibrosis
6个月前
已完结
Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?
6个月前
已完结
CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status
9个月前
已完结
Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
10个月前
已完结
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
10个月前
已完结
Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs
11个月前
已关闭
Pharmaceutical In Situ Gel for Glaucoma: Recent Trends and Development with an Update on Research and Patents
11个月前
已完结
A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes
11个月前
已完结
Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling
1年前
已完结
皖公网安备34019202002308
